Converge Bio
United States·North America·Biotechnology
About
Converge Bio is a generative AI lab for life sciences, accelerating drug development. It uses bio-LLMs for innovations in discovery, molecule design, and manufacturing optimization.
Funding history
Series A$25.0M
Jan 13, 2026
Bessemer Venture PartnersTLV PartnersVintage Investment PartnersSaras Capitalexecutives from MetaOpenAI and Wiz
Quick stats
- Total raised
- $25.0M
- Last round
- Series A
- Round date
- Jan 13, 2026
- Total rounds
- 1
Founders
Dov Gertz, Iddo Weiner, Oded Kalev